{"id":4449,"date":"2025-03-03T11:33:45","date_gmt":"2025-03-03T10:33:45","guid":{"rendered":"https:\/\/afpca.fr\/site\/?p=4449"},"modified":"2025-03-03T11:48:30","modified_gmt":"2025-03-03T10:48:30","slug":"plan-national-maladies-4-2025-2030","status":"publish","type":"post","link":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/","title":{"rendered":"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030)"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Les maladies rares concernent environ 3 millions de personnes en France. La France est le premier pays europ\u00e9en \u00e0 avoir mis en \u0153uvre un plan national, et l’organisation de la recherche et de la formation en la mati\u00e8re est reconnue \u00e0 l’international. Un 4e plan national consacr\u00e9 aux maladies rares<\/a> a \u00e9t\u00e9 d\u00e9voil\u00e9 le 25 f\u00e9vrier 2025<\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Les maladies rares concernent environ 3 millions de personnes en France. La France est le premier pays europ\u00e9en \u00e0 avoir mis en \u0153uvre un plan national, et l’organisation de la recherche et de la formation en la mati\u00e8re est reconnue \u00e0 l’international. Un 4e plan national consacr\u00e9 aux maladies rares a \u00e9t\u00e9 d\u00e9voil\u00e9 le 25 […]<\/p>\n","protected":false},"author":10,"featured_media":4462,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-4449","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","6":"hentry","7":"category-non-classe","9":"post-with-thumbnail","10":"post-with-thumbnail-large"},"yoast_head":"\nF\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030) - Association Francophone Contre La Polychondrite Chronique Atrophiante<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030) - Association Francophone Contre La Polychondrite Chronique Atrophiante\" \/>\n<meta property=\"og:description\" content=\"Les maladies rares concernent environ 3 millions de personnes en France. La France est le premier pays europ\u00e9en \u00e0 avoir mis en \u0153uvre un plan national, et l’organisation de la recherche et de la formation en la mati\u00e8re est reconnue \u00e0 l’international. Un 4e plan national consacr\u00e9 aux maladies rares a \u00e9t\u00e9 d\u00e9voil\u00e9 le 25 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/\" \/>\n<meta property=\"og:site_name\" content=\"Association Francophone Contre La Polychondrite Chronique Atrophiante\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/42710644010\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T10:33:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-03T10:48:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/03\/plmra_mini.png\" \/>\n\t<meta property=\"og:image:width\" content=\"194\" \/>\n\t<meta property=\"og:image:height\" content=\"246\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"webmaster_afpca\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster_afpca\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/\"},\"author\":{\"name\":\"webmaster_afpca\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/person\\\/51c98554e1e9914c58daecf2d0e9822e\"},\"headline\":\"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030)\",\"datePublished\":\"2025-03-03T10:33:45+00:00\",\"dateModified\":\"2025-03-03T10:48:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/\"},\"wordCount\":65,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/plmra_mini.png\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/\",\"name\":\"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030) - Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/plmra_mini.png\",\"datePublished\":\"2025-03-03T10:33:45+00:00\",\"dateModified\":\"2025-03-03T10:48:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#primaryimage\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/plmra_mini.png\",\"contentUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/plmra_mini.png\",\"width\":194,\"height\":246},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/plan-national-maladies-4-2025-2030\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\",\"name\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"description\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"publisher\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/afpca.fr\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\",\"name\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/LOGO_afpca.png\",\"contentUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/LOGO_afpca.png\",\"width\":184,\"height\":184,\"caption\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/42710644010\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/person\\\/51c98554e1e9914c58daecf2d0e9822e\",\"name\":\"webmaster_afpca\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g\",\"caption\":\"webmaster_afpca\"},\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/author\\\/webmaster_afpca\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030) - Association Francophone Contre La Polychondrite Chronique Atrophiante","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/","og_locale":"fr_FR","og_type":"article","og_title":"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030) - Association Francophone Contre La Polychondrite Chronique Atrophiante","og_description":"Les maladies rares concernent environ 3 millions de personnes en France. La France est le premier pays europ\u00e9en \u00e0 avoir mis en \u0153uvre un plan national, et l’organisation de la recherche et de la formation en la mati\u00e8re est reconnue \u00e0 l’international. Un 4e plan national consacr\u00e9 aux maladies rares a \u00e9t\u00e9 d\u00e9voil\u00e9 le 25 […]","og_url":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/","og_site_name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","article_publisher":"https:\/\/www.facebook.com\/groups\/42710644010","article_published_time":"2025-03-03T10:33:45+00:00","article_modified_time":"2025-03-03T10:48:30+00:00","og_image":[{"width":194,"height":246,"url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/03\/plmra_mini.png","type":"image\/png"}],"author":"webmaster_afpca","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"webmaster_afpca"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#article","isPartOf":{"@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/"},"author":{"name":"webmaster_afpca","@id":"https:\/\/afpca.fr\/site\/#\/schema\/person\/51c98554e1e9914c58daecf2d0e9822e"},"headline":"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030)","datePublished":"2025-03-03T10:33:45+00:00","dateModified":"2025-03-03T10:48:30+00:00","mainEntityOfPage":{"@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/"},"wordCount":65,"commentCount":0,"publisher":{"@id":"https:\/\/afpca.fr\/site\/#organization"},"image":{"@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#primaryimage"},"thumbnailUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/03\/plmra_mini.png","inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/","url":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/","name":"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030) - Association Francophone Contre La Polychondrite Chronique Atrophiante","isPartOf":{"@id":"https:\/\/afpca.fr\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#primaryimage"},"image":{"@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#primaryimage"},"thumbnailUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/03\/plmra_mini.png","datePublished":"2025-03-03T10:33:45+00:00","dateModified":"2025-03-03T10:48:30+00:00","breadcrumb":{"@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#primaryimage","url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/03\/plmra_mini.png","contentUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/03\/plmra_mini.png","width":194,"height":246},{"@type":"BreadcrumbList","@id":"https:\/\/afpca.fr\/site\/plan-national-maladies-4-2025-2030\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/afpca.fr\/site\/"},{"@type":"ListItem","position":2,"name":"F\u00e9vrier 2025 : Plan national maladies rares 4 (2025-2030)"}]},{"@type":"WebSite","@id":"https:\/\/afpca.fr\/site\/#website","url":"https:\/\/afpca.fr\/site\/","name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","description":"Association Francophone Contre La Polychondrite Chronique Atrophiante","publisher":{"@id":"https:\/\/afpca.fr\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/afpca.fr\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/afpca.fr\/site\/#organization","name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","url":"https:\/\/afpca.fr\/site\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/afpca.fr\/site\/#\/schema\/logo\/image\/","url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2023\/05\/LOGO_afpca.png","contentUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2023\/05\/LOGO_afpca.png","width":184,"height":184,"caption":"Association Francophone Contre La Polychondrite Chronique Atrophiante"},"image":{"@id":"https:\/\/afpca.fr\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/42710644010"]},{"@type":"Person","@id":"https:\/\/afpca.fr\/site\/#\/schema\/person\/51c98554e1e9914c58daecf2d0e9822e","name":"webmaster_afpca","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g","caption":"webmaster_afpca"},"url":"https:\/\/afpca.fr\/site\/author\/webmaster_afpca\/"}]}},"_links":{"self":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts\/4449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/comments?post=4449"}],"version-history":[{"count":10,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts\/4449\/revisions"}],"predecessor-version":[{"id":4464,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts\/4449\/revisions\/4464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/media\/4462"}],"wp:attachment":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/media?parent=4449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/categories?post=4449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/tags?post=4449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}